Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Metabolic Brain Disease
Metadata
Title
Subject Index to Volume 13 (1998)
Publication date
01-12-1998
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Metabolic Brain Disease / Issue 4/1998
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1023/A:1020601328627

Other articles of this Issue 4/1998

Metabolic Brain Disease 4/1998 Go to the issue

OriginalPaper

Psychiatric Aspects of Portal-Systemic Encephalopathy

OriginalPaper

Role of Manganese in the Pathogenesis of Portal-Systemic Encephalopathy

OriginalPaper

Astroglial Dysfunction in Hepatic Encephalopathy

OriginalPaper

Proton Magnetic Resonance Spectroscopy in Portal-Systemic Encephalopathy

OriginalPaper

Positron Emission Tomography in the Study of Hepatic Encephalopathy

OriginalPaper

Cerebral Magnetic Resonance Imaging in Patients with Chronic Liver Disease